These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17252609)

  • 1. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note.
    Gao Z; Moore T; Smith AP; Doub W; Westenberger B; Buhse L
    AAPS PharmSciTech; 2007 Oct; 8(4):E82. PubMed ID: 18181543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The random vibration effects on dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Buhse LF; Doub WH
    J Pharm Sci; 2009 Jan; 98(1):297-306. PubMed ID: 18399543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibration effects on dissolution tests with USP apparatuses 1 and 2.
    Gao Z; Moore TW; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3335-43. PubMed ID: 18000813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution.
    Röst M; Quist PO
    J Pharm Biomed Anal; 2003 Apr; 31(6):1129-43. PubMed ID: 12667929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved drug dissolution and product characterization using a crescent-shaped spindle.
    Qureshi SA
    J Pharm Pharmacol; 2004 Sep; 56(9):1135-41. PubMed ID: 15324482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vessel geometric irregularity on dissolution test results.
    Gao Z; Ahadi S; Moore TW; Doub WH; Westenberger BJ; Buhse LF
    J Pharm Sci; 2011 Mar; 100(3):1093-101. PubMed ID: 20803604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products.
    Yu LX; Wang JT; Hussain AS
    AAPS PharmSci; 2002; 4(1):E1. PubMed ID: 12049485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the use of a 200 ml vessel suitable for dissolution of low dose drug products?
    Crail DJ; Tunis A; Dansereau R
    Int J Pharm; 2004 Jan; 269(1):203-9. PubMed ID: 14698592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of tablet dissolution.
    Nott KP
    Eur J Pharm Biopharm; 2010 Jan; 74(1):78-83. PubMed ID: 19602436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling of variables involved in dissolution testing.
    Gao Z
    J Pharm Sci; 2011 Nov; 100(11):4934-42. PubMed ID: 21702052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typical variability and evaluation of sources of variability in drug dissolution testing.
    Siewert M; Weinandy L; Whiteman D; Judkins C
    Eur J Pharm Biopharm; 2002 Jan; 53(1):9-14. PubMed ID: 11777747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.